NCT06461741

Brief Summary

The goal of this clinical trial is to test the impact of a novel dual-task EMG Biofeedback training method for improving balance in individuals living with multiple sclerosis. The main question\[s\] it aims to answer are:

  • Does dual-task EMG biofeedback training deliver lasting balance benefits up to 3 months following the intervention?
  • Are the benefits greater than those for participation in traditional balance training exercises?
  • Do the benefits vary with the severity of disability? Participants will receive either EMG Biofeedback (EMG-BF) training or traditional balance exercise (BAL-EX) training. Both treatments involve three 30-minute sessions of the training every week for 6 weeks (18 sessions). During the sessions, participants in the EMG-BF treatment group will perform targeted exercises using feedback from adhesive (sticker) sensors on their arms and legs. Participants in the BAL-EX treatment group will following an instructor through balance training movements that are traditionally prescribed by physiotherapists to improve balance. Measurements will be taken at the beginning of the study, after six weeks of training, and three months after the end of training. Researchers will compare the groups to see if balance and related outcomes are improved more by 6-weeks of EMG-BF training than BAL-EX.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
14mo left

Started Oct 2024

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Oct 2024Jul 2027

First Submitted

Initial submission to the registry

June 10, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 17, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

December 3, 2024

Status Verified

June 1, 2024

Enrollment Period

1.7 years

First QC Date

June 10, 2024

Last Update Submit

November 29, 2024

Conditions

Keywords

BalanceFalls

Outcome Measures

Primary Outcomes (1)

  • Mini-Balance Evaluation Systems Test (Mini-BESTest)

    A sensitive, reliable, and valid 14-item scale that assesses dynamic balance. It includes components evaluating anticipatory postural adjustments, responses to perturbation, sensory orientation, and dynamic stability during gait. The total score ranges from 0 ("no balance") to 28 ("complete balance").

    It will be measured at baseline, 6 weeks of training, and 3 months after the end of training (18 weeks from baseline)

Secondary Outcomes (7)

  • Limits of Stability (LoS)

    It will be measured at baseline, 6 weeks of training, and 3 months after the end of training (18 weeks from baseline)

  • Sway in Quiet Stance (QS)

    It will be measured at baseline, 6 weeks of training, and 3 months after the end of training (18 weeks from baseline)

  • Timed 25ft Walk Test (T25WT)

    It will be measured at baseline, 6 weeks of training, and 3 months after the end of training (18 weeks from baseline)

  • Activities-specific Balance Confidence (ABC) scale

    It will be measured at baseline, 6 weeks of training, and 3 months after the end of training (18 weeks from baseline)

  • 12-item Subjective Walking Scale (SWS-12)

    It will be measured at baseline, 6 weeks of training, and 3 months after the end of training (18 weeks from baseline)

  • +2 more secondary outcomes

Other Outcomes (2)

  • Visual Analog Scales (VAS)

    The weekly 3-session average will be assessed for week 1, 2, 3, 4, 5 and 6. the average across all six weeks (18 sessions) will be assessed.

  • Enjoyment Scale (ES)

    6 weeks of training.

Study Arms (2)

Integrated Dual-task EMG Biofeedback Training (EMG-BF)

EXPERIMENTAL

Participants will engage in EMG-BF for 30 minutes 3 times per week for 6 weeks for a total of 18 sessions. Our novel EMG Biofeedback training system can be adapted to a training objective by planning 3 to 5 movements and placing sensors over muscles that must be active when the user adheres to the correct movement form. For our training we use right or left torso shift with knee bend, and right or left hand opening, and place sensors over left and right vastus lateralis and left and right extensor digitorum superficialis muscles. Each movement corresponds to a specific videogame command. To introduce cognitive challenge, we randomly shuffle the game command assigned to each movement at the beginning of every session. This will require the user to choose the appropriate movement to trigger the intended game input while suppressing incorrect movements. We use the puzzle game, Tetris, which requires spatial reasoning and planning under increasingly tight time constraints.

Device: Integrated Dual-task EMG Biofeedback Training (EMG-BF)

Traditional Balance Exercise Training (BAL-EX)

ACTIVE COMPARATOR

Participants will perform 7 balance exercises traditionally prescribed by physiotherapists. The first is a heel/toe square exercise where the trainee lifts their right toe and left heel, then their left toe and right heel, then both heels, then both toes. The 2nd exercise involves maintaining tandem stance while static, then moving the arms, then looking up and down, then looking left and right. The 3rd exercise is lateral stepping where the individual steps with one foot out to the side and then bring the foot back to the starting stance. The 4th exercise is a golfer's lift where the person slowly leans forward while extending one leg straight behind and touches the seat of a chair placed opposite. The 5th exercise is extended-duration single leg stands and exercises 6 and 7 are back and side leg raises, respectively. The exercise sequence will repeat until 30 minutes has expired. Sessions are repeated 3 times per week for 6 weeks, for 18 sessions.

Behavioral: Traditional Balance Exercise Training (BAL-EX)

Interventions

The intervention is an exercise training that is facilitated by feedback derived from electrical muscle activity measured through electromyography (EMG). An EMG Biofeedback software uses a machine learning algorithm to identify the desired movements and reinforce them by displaying feedback on a computer monitor in the form of videogame control. The EMG acquisition hardware must have at least 4 sensor channels and a sampling rate of \>1KHz. Other than these specifications, any generic EMG amplifier can be used. The effect of the "device" is therefore primarily defined by the software. An in-depth description of the software and hardware systems is published in the cites study, "An EMG-Based Biofeedback System for Tailored Interventions Involving Distributed Muscles". In this trail is the Explore+ ExG amplifier which is sold by Mentalab.

Integrated Dual-task EMG Biofeedback Training (EMG-BF)

This intervention is a time-matched active comparator for the EMG-BF intervention. A sequence of seven traditional, balance exercises, taking 1-3 minutes each, is repeated for a total of 30 minutes on each of 18 sessions in the 6-week intervention period. The exercises are ones that challenge the coordination and strength of postural muscles in the presence of various vestibular stimuli. The specific exercises are described in the Arm description.

Traditional Balance Exercise Training (BAL-EX)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-80 years with a formal diagnosis of MS.
  • Participants must be ambulatory and report problems with walking and/or balance.
  • Have stable disease with no relapses in the last 3 months.
  • Agreement to not introduce or change the dosage of pharmaceutical treatments during the study period. This includes intramuscular injections (e.g., Botox), intravenous, and orally administered drugs.
  • Agreement to maintain the frequency, duration and intensity of physical therapy or any alternate therapies (e.g., massage, osteopathic, chiropractic, etc.) for the duration of the trial.

You may not qualify if:

  • Unable to follow instructions due to cognitive deficit or language barrier
  • Presence of visual disorders that prevent meaningful interaction with the intervention interface.
  • Unable to maintain stable pharmaceutical treatment for the duration of the study.
  • Unable to maintain the frequency, duration and intensity of physical therapy or alternate therapies outside of the trial for the duration of the trial.
  • Received Botox treatment within 3 months of the onset of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McMaster University

Hamilton, Ontario, L8S4L1, Canada

RECRUITING

Related Publications (1)

  • Toepp SL, Mohrenschildt MV, and Nelson AJ. An EMG-Based Biofeedback System for Tailored Interventions Involving Distributed Muscles. IEEE Sensors Journal. 2024; 23(22): 28095-28109.

    BACKGROUND

Related Links

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Aimee J Nelson, PhD

CONTACT

Stephen L Toepp, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 10, 2024

First Posted

June 17, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

December 3, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations